| Literature DB >> 32670961 |
Shilpa Gaidhane1,2, Nazli Khatib3,4, Quazi Syed Zahiruddin5,6, Anand Bang7, Sonali Choudhari5,8, Abhay Gaidhane5,9.
Abstract
INTRODUCTION: Despite evidence in support of assessment and treatment of risk factors to prevent cardiovascular disease (CVD) among people with type 2 diabetes mellitus (T2DM), studies have shown gaps in practises at the primary care level. The study was undertaken to find out the prevalence and management of risk factors for CVD in patients with T2DM from rural area India.Entities:
Keywords: Cardiovascular disease; prevention; risk assessment; risk factors; type 2 diabetes mellitus
Year: 2020 PMID: 32670961 PMCID: PMC7346927 DOI: 10.4103/jfmpc.jfmpc_1192_19
Source DB: PubMed Journal: J Family Med Prim Care ISSN: 2249-4863
Characteristics of the study population
| Characteristics | No ( | Percent | |
|---|---|---|---|
| Age group (years) | 31 to 40 | 12 | 6.3 |
| 41 to 50 | 38 | 19.8 | |
| 51 to 60 | 54 | 28.1 | |
| More than 60 | 88 | 45.8 | |
| Sex | Male | 120 | 62.5 |
| Female | 72 | 37.5 | |
| Residence | Rural | 134 | 69.8 |
| Urban | 58 | 30.2 | |
| Current tobacco use (smoking + Other forms), No (%) | 130 | 67.7 | |
| Currently use alcohol, No (%) | 52 | 27.1 | |
| Physical activity | 84 | 43.8 | |
| Green leafy vegetables or/and fruits | < 3 servings per week | 148 | 77.1 |
| 3 to 6 servings per week | 40 | 20.8 | |
| > 6 servings per week | 4 | 2.1 | |
| Body Mass Index (BMI) | Underweight | 38 | 19.8 |
| Normal | 100 | 52.1 | |
| Overweight (25-29.9) | 44 | 22.9 | |
| Obesity (>=30) | 10 | 5.2 | |
| WHR | Less than 1 | 158 | 82.3 |
| More than or equal to 1 | 34 | 17.7 | |
Diabetes history, biochemical parameters and blood pressure among study participants
| No | Percent | ||
|---|---|---|---|
| Duration of DM | Recently diagnosed | 24 | 12.5 |
| 1 month to 5 years | 102 | 53.1 | |
| 5 years to 10 years | 30 | 15.6 | |
| More than 10 years | 36 | 18.8 | |
| Current antidiabetes medication | Biguinades | 68 | 35.4 |
| Insulin | 14 | 7.3 | |
| Sulphonylurea | 10 | 5.2 | |
| Biguinades + Sulphonylurea | 50 | 26 | |
| Biguinades + Insulin | 20 | 10.4 | |
| Biguinades + Insulin + Sulphonylurea | 12 | 6.2 | |
| Biguinades + Acarbose inhibitor | 4 | 2.1 | |
| Other combinations of above-mentioned drugs | 14 | 7.3 | |
| Biochemical parameters | RBS (mg/dL); mean (SD) | 279.16 (126.70) | |
| FBS (mg/dL); mean (SD) | 160.66 (76.38) | ||
| PMBS (mg/dL); mean (SD) | 243.73 (96.32) | ||
| T-Cholesterol (mg/dL); mean (SD) | 174.55 (48.63) | ||
| HDL, (mg/dL); mean (SD) | 38.88 (4.94) | ||
| LDL, (mg/dL); mean (SD) | 102.15 (35.04) | ||
| TG, (mg/dL); mean (SD) | 163.65 (87.96) | ||
| Blood pressure (mmHg) JNC 8 criteria | Normal | 52 | 27.1 |
| Prehypertension | 88 | 45.8 | |
| Hypertension, stage 1 | 42 | 21.9 | |
| Hypertension, stage 2 | 10 | 5.2 | |
Distribution of risk factors for CVD with the sex of the study participants
| Risk factors for CVD | Total | Male | Female | |
|---|---|---|---|---|
| Age; mean (SD) | 58.90 (11.30) | 58.10 (12.19) | 60.22 (9.65) | T=0.89; |
| F/H of CVD/HT/stroke; no (%) | 24 (12.5) | 12 (10) | 12 (16.7) | Chi=3.77; |
| BMI > = 25 kg/m2; no (%) | 54 (28.1) | 32 (26.7) | 22 (30.6) | Chi=168; |
| Waist circumference >90 cm for males and >80 cm in female; no (%) | 102 (53.1) | 82 (68.3) | 20 (27.8) | |
| WHR >1; no (%) | 34 (17.7) | 32 (26.7) | 2 (2.8) | |
| Current tobacco use; no (%) | 130 (67.7) | 92 (76.7) | 38 (52.8) | |
| Current alcohol; no (%) | 52 (27.1) | 48 (40) | 4 (5.6) | |
| Dietary risk factors; no (%) | 188 (97.9) | 116 (96.6) | 72 (100) | FET, |
| Physical inactivity; no (%) | 108 (56.2) | 64 (53.3) | 44 (61.1) | Chi=0.55, |
| SBP, > = 140 mmHg | 142 (74) | 96 (80) | 46 (63.9) | Chi=3.03; |
| DBP, > = 90 mmHg | 38 (19.8) | 32 (26.7) | 6 (8.3) | |
| RBS >200 mg/dL; no (%) | 76 (39.5) | 48 (60) | 28 (38.9) | FET, |
| FBS >100 mg/dL; no (%) | 106 (55.2) | 62 (51.7) | 44 (61.1) | Chi=1.42; |
| PMBS >140 mg/dL; no (%) | 120 (62.5) | 82 (68.3) | 38 (52.8) | Chi=0.35; |
| T-Cholesterol >200 mg/dL; no (%) | 138 (72) | 99 (82.6) | 39 (54.1) | FET, |
| HDL, < 50 mg/dL; no (%) | 184 (96) | 120 (100) | 64 (88.9) | FET, |
| LDL, > 100 mg/dL; no (%) | 77 (41.7) | 37 (30.8) | 40 (62.5) | FET, |
| TG, > 150 mg/dL; no (%) | 92 (48) | 45 (37.5) | 47 (65.3) | FET, |
CVD risk assessment and risk reduction interventions by participants in recent 6 months
| CVD risk assessment in recent 6 months and risk reduction interventions | No | Percentage |
|---|---|---|
| Assessment of CVD risk factors | ||
| Assessed for tobacco use | 61 | 31.8 |
| Assessed for Alcohol use | 36 | 18.8 |
| Assessed for nutrition/dietary intake | 34 | 17.7 |
| Assessed for physical activity | 33 | 17.2 |
| Estimated BMI | 28 | 14.6 |
| Measured Blood pressure | 160 | 83.3 |
| Blood sugar (FBS+PMBS) assessment | 76 | 39.6 |
| Lipid profile | 42 | 21.9 |
| Risk reduction interventions | ||
| Asprin | 19 | 9.9 |
| Statins | 11 | 5.7 |
| Clopidogril | 7 | 3.6 |
| Antihypertensive medications | 142 | 74.0 |
| ACE inhibitor | 64 | 45.1 |
| AT receptor blockage | 49 | 34.5 |
| Calcium channel blocker | 15 | 10.6 |
| Beta-blocker | 14 | 9.9 |
| Advised for low salt diet and blood pressure | 33 | 17.2 |
| Advised for quitting tobacco and cut down alcohol | 45 | 23.4 |
| Advised for physical activity and weight reduction | 56 | 29.2 |
| Counselled for dietary modification and diet plan prepared | 17 | 8.9 |